2 exciting ETFs named as buys by experts

Here are two ETFs that could be buys…

| More on:
A young woman sits with her hand to her chin staring off to the side thinking about her investments.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're wanting to buy some exchange traded funds (ETFs), then you certainly have a lot of options.

But which ones could be buys? Two that have been tipped as buys by analysts are listed below. Here's what they are saying about them:

ETFS Battery Tech & Lithium ETF (ASX: ACDC)

If you're wanting to get some exposure to the decarbonisation megatrend, then the ETFS Battery Tech & Lithium ETF could be one way to do it.

This popular ETF allows investors to buy a slice of companies involved in battery technology, electric vehicles, and lithium mining. This includes BYD, Mineral Resources Limited (ASX: MIN), Pilbara Minerals Ltd (ASX: PLS), Nissan, and Renault.

Jessica Amir from Saxo Markets is positive on the ETF. Especially for investors that aren't keen on stock picking in the lithium sector. She commented:

If stock picking is not for you, and if you believe, like we do, that the electric vehicle industry and the critical minerals/ commodities will continue to see rising demand, and policy support, and also benefit from the world striving to be carbon neutral by 2050, then you could invest or trade in Global X Lithium & Battery Tech ETF (LIT) or ETFS Battery Tech & Lithium ETF (ACDC) that invests in about 30 of the biggest EV and battery technology companies in the world.

ETFS S&P Biotech ETF (ASX: CURE)

Another ETF that has been tipped as a buy is the ETFS S&P Biotech ETF. As its name implies, this ETF gives investors access to U.S. healthcare biotechnology companies.

The fund manager notes that these companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering. This includes the development of immunotherapy treatments and vaccines to treat human diseases.

Among its largest holdings are ChemoCentryx, Global Blood Therapeutics, and Twist Bioscience.

Felicity Thomas from Shaw & Partners is a fan of the ETF. She recently told Livewire:

I like to buy ETFs for the long term. We have an ageing population, and what's the most important thing in the world? Your health. Biotech, healthcare, and life sciences, that's where you want to be invested over the next couple of decades.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ETFs

A panel of four judges hold up cards all showing the perfect score of ten out of ten
ETFs

3 of the best ASX ETFs for Australian investors to buy now

Let's see what makes these funds stand out from the rest.

Read more »

A wide-eyed happy woman with long brown hair and wearing a pink top holds her hands up in delight after hearing positive news
ETFs

4 ASX ETFs that produced 110% to 150% returns in 2025

These 4 ASX ETFs have a common thread (besides their remarkable returns!)

Read more »

A person leans over to whisper a secret to a colleague during a meeting.
ETFs

Should Aussie investors have exposure to Chinese equities in 2026? – Expert 

The Chinese AI boom has been gaining steam - is it a long-term play?

Read more »

A businessman in a suit wears a medal around his neck and raises a fist in victory surrounded by two other businessmen in suits facing the other direction to him.
ETFs

Global X releases new ASX ETF targeting silver shares

Think the silver rally can continue? This ASX ETF might be for you.

Read more »

A casually dressed woman at home on her couch looks at index fund charts on her laptop
ETFs

3 Vanguard ETFs for smart investors to buy in February

A simple mix of global value, Asian growth, and broad international exposure can help build a resilient long-term portfolio.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Opinions

VAS and IVV: 3 reasons these two ASX ETFs belong in a long-term portfolio

Here's why I think these shares are a no-brainer.

Read more »

Man holding Australian dollar notes, symbolising dividends.
ETFs

5 ASX ETFs to buy for passive income

These five funds could be used by investors to generate income.

Read more »

Woman in an office crosses her arms in front of her in a stop gesture.
ETFs

2 ASX ETFs to avoid in February

Some ETFs that work well in one market can quietly disappoint in another.

Read more »